Efficacy of immune checkpoint inhibitors in advanced large cell neuroendocrine carcinoma of the lung: A single‑institution experience.

导出 OA

翻译打印收藏纠错

第一作者： Ningning,Yan

第一单位： Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450002, P.R. China.

作者： Ningning,Yan ^[1] ; Sanxing,Guo ^[1] ; Ziheng,Zhang ^[1] ; Shujing,Shen ^[2] ; Xingya,Li ^[1]

作者单位： Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450002, P.R. China. ^[1] Department of Radiation Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450002, P.R. China. ^[2]

关键词 clinical management immunotherapy large cell neuroendocrine carcinoma lung cancer prognostic factors

DOI 10.3892/ol.2024.14268

PMID 38357477

发布时间 2024-02-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交